In collaboration with INBB and University of Parma, Adamas Biotech has published its preclinical research on green tea catechins' cardioprotective effects on the diabetic heart and their mechanism of action.…

Forbes magazine, in its new editorial "Small Giants," has featured Cube Labs in its list of 100 Companies of Champions, highlighting the COVID-19 prophylactic technology codeveloped by Adamas Biotech and…

August 2021 Rome, Italy Professor Saverio Bettuzzi, member of the Istituto Nazionale Biostrutture e Biosistemi of Rome, Italy, has published proof of concept data for the treatment of COVID-19 syndrome…